Member Info for Barbershop

Good to see positive update from Vlad, nice to hear CBR is being progressed in the background while everyone is obsessing on IND.

Vlad looked tired, also disappointed with the delay due to clinical hold, both are understandable, but dispite that he seems upbeat about progress.

Overall a good antidote to the negative posts by some on here, will be looking to further reduce average over next few months and hopefully we'll get something positive after that to lift the mood.

Here until phase 2 results anyway, expect a bumpy road along the way...

Have to say this hasnt played out as well as I'd hoped since buying in at 7p, then again at 5p, and then along the way to end up with a 2.58p average...but to hear that HT wouldnt want to hang socially is a real low point for me...I mean, to hell with the money, that's come as a real blow...

Will keep looking to top up at these low levels, but have to say, my mood is much lower than the SP at this point...

Seems to be a lot of hot air over what is potentially just a 2 month delay.

Buy more, worry less....

Could be because the company is slow to keep us informed, there are often days with no buys/sells, and there's the potential for a fund raise relatively soon.

Hopefully an open offer to sort out short term financial concerns, and then income from new deal will be enough for cash flow thereafter.

Why dont we reconviene next Monday / Tuesday and see who was right?

Never understood why you guys feel the need to post every day, and often many times a day?

Even if you've got nothing else to do with your time, there are plenty of other companies you could research rather than wasting time on conjecture here.

Unless all of you crammed every last penny you have in here it just doesn't make sense.

Have to say stu you've really earned the pid with that post.

How could you think that options are granted as anything other than an incentive to employees to in the expectation they would be exercised at a point the company valuation is higher than the option price?

You're keen to ask others for examples, so please provide one where anyone has exercised options where the company valuation and the option price have been the same...

I was referring to CARM not Hemo, just had a quick look at their last two quarterlies.

Seems a little short on cash in the bank.

One to keep a eye on maybe, but would be worried about need to raise cash.

Nice rerate today, long overdue but time to break out the champers.

Congrats to all the LTH, we made it guys...

It seems you're not familiar with the work of Abbot and Costello...

Ah my bad, just looked back at earlier posts about the grant...still would be nice to know if Vlad applied or not.

Don't keep us in suspense HT, who declared COVID is over?

Doesn't look like we're getting any funding from the bio-defense fund:

https://www.governor.ny.gov/news/governor-hochul-announces-more-8-million-awards-through-new-york-state-biodefense

Not this year anyway...

The Jeep Avenger looks pretty good and reviews seem positive.

Might be a little on the small side, but depends what you're looking for.

If this ever does rerate, will probably get one of those.

Hoping for news from the NY Grant fund today, based only on the fact last year's announcement was on a Monday.

Let's see what happens this afternoon...

Well you certainly cleared your airwaves with that post!!

Sounds more likely you don't get tongue in cheek...obviously there's no correlation between everyone on the board complaining about a tooth ailment and FF.

Staring to worry that FF might cause tooth decay.

Had my first filling recently, but other than that no other work...will keep you all updated if that changes...

Wouldn't that wipe out Mooky's equity as well, leaving him with massive debts?

Not saying it isn't going to happen, but not seeing his exit strategy.

Phase 2 tests efficacy, phase 1 makes sure there are no serious side effects.

Where's the silver lining on this one:

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-seeks-more-rigorous-trials-cancer-drugs-accelerated-nod-2023-03-24/